|
|
Volumn 26, Issue 5-6, 2001, Pages 739-752
|
|
Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: Issues concerning assay specificity and quality control preparation
a
c
RY800 B211
*
(United States)
|
|
Author keywords
3 agonist; LC MS MS; Liquid liquid extraction
|
|
Indexed keywords
2 PROPANOL;
BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;
BOVINE SERUM ALBUMIN;
DRUG METABOLITE;
SULFONAMIDE;
TERT BUTYL METHYL ETHER;
UNCLASSIFIED DRUG;
UREIDOBENZENESULFONAMIDE;
UREIDOBENZENESULFONAMIDE DERIVATIVE;
ACCURACY;
ARTICLE;
CHEMICAL REACTION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DESIGN;
DRUG DETERMINATION;
DRUG METABOLISM;
DRUG STRUCTURE;
DRUG URINE LEVEL;
EVAPORATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INTERMETHOD COMPARISON;
OBESITY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY CONTROL;
QUANTITATIVE ASSAY;
TANDEM MASS SPECTROMETRY;
URINALYSIS;
WEIGHT REDUCTION;
ADRENERGIC BETA-AGONISTS;
BIOTRANSFORMATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DOUBLE-BLIND METHOD;
HUMANS;
HYDROGEN-ION CONCENTRATION;
INDICATORS AND REAGENTS;
MASS SPECTROMETRY;
QUALITY CONTROL;
REFERENCE STANDARDS;
SERUM ALBUMIN, BOVINE;
SPECTROPHOTOMETRY, ULTRAVIOLET;
SULFONAMIDES;
TETRAZOLES;
|
|
EID: 0034798136
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/S0731-7085(01)00438-1 Document Type: Article |
|
Times cited : (13)
|
|
References (6)
|
